Supramolecular Pharmaceutical Sciences: A Novel Concept Combining Pharmaceutical Sciences and Supramolecular Chemistry with a Focus on Cyclodextrin-Based Supermolecules

Chem Pharm Bull (Tokyo). 2018;66(3):207-216. doi: 10.1248/cpb.c17-00765.

Abstract

Supramolecular chemistry is an extremely useful and important domain for understanding pharmaceutical sciences because various physiological reactions and drug activities are based on supramolecular chemistry. However, it is not a major domain in the pharmaceutical field. In this review, we propose a new concept in pharmaceutical sciences termed "supramolecular pharmaceutical sciences," which combines pharmaceutical sciences and supramolecular chemistry. This concept could be useful for developing new ideas, methods, hypotheses, strategies, materials, and mechanisms in pharmaceutical sciences. Herein, we focus on cyclodextrin (CyD)-based supermolecules, because CyDs have been used not only as pharmaceutical excipients or active pharmaceutical ingredients but also as components of supermolecules.

Keywords: cyclodextrin (CyD); pharmaceutical sciences; polycatenane; polyrotaxane; supramolecular chemistry; supramolecular pharmaceutical sciences.

Publication types

  • Review

MeSH terms

  • Animals
  • Cyclodextrins / chemistry*
  • Cyclodextrins / therapeutic use
  • Drug Carriers / chemistry
  • Drug Discovery
  • Humans
  • Hydrogels / chemistry
  • Niemann-Pick Disease, Type C / drug therapy
  • Poloxamer / chemistry
  • Rotaxanes / chemistry

Substances

  • Cyclodextrins
  • Drug Carriers
  • Hydrogels
  • Rotaxanes
  • polyrotaxane
  • Poloxamer